Kare Chemical Technologies
Mississauga, CA · 2 known investors
Find your way into Kare Chemical Technologies
Kare Chemical Technologies is a pharmaceutical technology company using a patented catalytic process to convert limonene, a citrus by-product, into high-purity CB1 and CB2 receptor ligands for drug development. It develops non-psychoactive therapeutic candidates aimed at safer alternatives to opioids and next-generation metabolic therapies.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedOct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Kare Chemical Technologies do?
- Kare Chemical Technologies is a pharmaceutical technology company using a patented catalytic process to convert limonene, a citrus by-product, into high-purity CB1 and CB2 receptor ligands for drug development. It develops non-psychoactive therapeutic candidates aimed at safer alternatives to opioids and next-generation metabolic therapies.
- Who are Kare Chemical Technologies's investors?
- Kare Chemical Technologies's investors include Ontario Centre of Innovation, Ontario Centre of Innovation programs.
- Where is Kare Chemical Technologies headquartered?
- Kare Chemical Technologies is headquartered in Mississauga, CA.